San Francisco, CA, United States of America

Jeff Royal

USPTO Granted Patents = 4 


Average Co-Inventor Count = 7.5

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeff Royal in Cardiovascular Technology

Introduction

Jeff Royal is a notable inventor based in San Francisco, CA, whose work has significantly advanced the field of cardiovascular technology. With four patents to his name, Royal has demonstrated his commitment to innovation and improving patient outcomes through his remarkable inventions.

Latest Patents

Among his latest contributions are two significant patents related to stent technology. The first patent, titled "Method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin," presents a method that ensures less than 50% of the total amount of 40-O-(2-hydroxy)ethyl-rapamycin, or its analogs and derivatives, is released in vivo within a 24-hour period. This method involves exposing the coating to a sufficient temperature to modify the structure of the polymer, enhancing the stent's effectiveness.

The second patent, "40-O-(2-hydroxy)ethyl-rapamycin coated stent," discloses a method and coating designed to reduce the release rate of an active agent from implantable devices, such as stents. This innovation aims to improve the longevity and efficacy of stent treatments, making them safer and more effective for patients.

Career Highlights

Jeff Royal currently works at Advanced Cardiovascular Systems, Inc., a company dedicated to developing innovative solutions in cardiovascular devices. His role at this leading organization has allowed him to contribute to cutting-edge research and development, further advancing the field of cardiovascular health. His patents reflect his focus on improving stent technologies that can drastically change treatment protocols for patients requiring such interventions.

Collaborations

Throughout his career, Royal has collaborated with talented professionals in the industry, including Syed F A Hossainy and Kurt W Scheinpflug. These collaborations have fostered a rich environment for innovation and shared knowledge, essential in driving advancements in cardiovascular technology.

Conclusion

In conclusion, Jeff Royal's innovative work in stent technology exemplifies how determination and creativity can lead to significant advancements in medical devices. His patents not only enhance the efficacy of treatments but also underline the importance of continual innovation in improving patient care. As a key player in the field, Royal’s contributions will likely have a lasting impact on cardiovascular health and medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…